SABS Historical Earnings image   This SABS historical earnings page last updated 8/12/2022
SABS Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/10/20220.01B
Q1 20225/12/20220.01B
SABS Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/10/2022-0.110
Q1 20225/12/20220.020
Quotes delayed 20 minutes

Email EnvelopeFree SABS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
SAB Biotherapeutics (SABS) is categorized under the Miscellaneous sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SBBP Historical Earnings
SEAT Historical Earnings
SHCR Historical Earnings
SHPW Historical Earnings
SKIL Historical Earnings
SKIN Historical Earnings
SLDP Historical Earnings
SLGC Historical Earnings
SMFR Historical Earnings
SMR Historical Earnings
What was the record high SABS historical earnings result?
In terms of earnings or revenue, what is the best SABS historical earnings result that SAB Biotherapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest SABS historical earnings result was set in Q1 2022, when SAB Biotherapeutics posted results of 0.020/share. The most successful revenue quarter within our data set was Q1 2022 when SAB Biotherapeutics reported revenue of 0.01B.

What was the lowest SAB Biotherapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest SABS has reported, and when?

✔️Accepted answer: Within our data set, the lowest SABS historical earnings result was set in Q2 2022, when SAB Biotherapeutics posted results of -0.110/share. The smallest revenue quarter within our data set was Q2 2022 when SAB Biotherapeutics reported revenue of 0.01B.

On this page we presented the SABS historical earnings date information for SAB Biotherapeutics. Reviewing that SABS Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2022, when SABS posted gaap of 0.020/share. Meanwhile the lowest SABS historical earnings result was in Q2 2022, when SABS posted gaap of -0.110/share. Moving to SAB Biotherapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2022 when SABS reported 0.01B in revenue, while the smallest revenue quarter was Q2 2022 when SABS reported 0.01B in revenue.

For self directed investors doing their due diligence on SABS or any other given stock, their research can benefit from looking into all of the SAB Biotherapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into SAB Biotherapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for SABS. Thanks for visiting, and the next time you need to research SABS historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Institutional Holders of UIVM, FRSH Price Target, HCKT Price Target.

 

SABS Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.